Cargando…
Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder
Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dos...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054796/ https://www.ncbi.nlm.nih.gov/pubmed/32148990 http://dx.doi.org/10.1155/2020/2615748 |
_version_ | 1783503258904428544 |
---|---|
author | Kuo, Joseph Lin, Shih-Ku |
author_facet | Kuo, Joseph Lin, Shih-Ku |
author_sort | Kuo, Joseph |
collection | PubMed |
description | Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole. |
format | Online Article Text |
id | pubmed-7054796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-70547962020-03-06 Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder Kuo, Joseph Lin, Shih-Ku Case Rep Psychiatry Case Report Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole. Hindawi 2020-02-21 /pmc/articles/PMC7054796/ /pubmed/32148990 http://dx.doi.org/10.1155/2020/2615748 Text en Copyright © 2020 Joseph Kuo and Shih-Ku Lin. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Kuo, Joseph Lin, Shih-Ku Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title | Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title_full | Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title_fullStr | Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title_full_unstemmed | Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title_short | Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder |
title_sort | using extended-release injectable aripiprazole for the successful treatment of depressive symptoms in bipolar i disorder |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054796/ https://www.ncbi.nlm.nih.gov/pubmed/32148990 http://dx.doi.org/10.1155/2020/2615748 |
work_keys_str_mv | AT kuojoseph usingextendedreleaseinjectablearipiprazoleforthesuccessfultreatmentofdepressivesymptomsinbipolaridisorder AT linshihku usingextendedreleaseinjectablearipiprazoleforthesuccessfultreatmentofdepressivesymptomsinbipolaridisorder |